Literature DB >> 11418663

Structural effects of framework mutations on a humanized anti-lysozyme antibody.

M A Holmes1, T N Buss, J Foote.   

Abstract

A humanized version of the mouse anti-lysozyme Ab D1.3 was previously constructed as an Fv fragment and its structure was crystallographically determined in the free form and in complex with lysozyme. Here we report five new crystal structures of single-amino acid substitution mutants of the humanized Fv fragment, four of which were determined as Fv-lysozyme complexes. The crystals were isomorphous with the parent forms, and were refined to free R values of 28-31% at resolutions of 2.7-2.9 A. Residue 27 in other Abs has been implicated in stabilizing the conformation of the first complementarity-determining region (CDR) of the H chain, residues 31-35. We find that a Phe-to-Ser mutation at 27 alters the conformation of immediately adjacent residues, but this change is only weakly transmitted to Ag binding residues in the nearby CDR. Residue 71 of the H chain has been proposed to control the relative disposition of H chain CDRs 1 and 2, based on the bulk of its side chain. However, in structures we determined with Val, Ala, or Arg substituted in place of Lys at position 71, no significant change in the conformation of CDRs 1 and 2 was observed.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11418663     DOI: 10.4049/jimmunol.167.1.296

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  10 in total

1.  Critical contribution of VH-VL interaction to reshaping of an antibody: the case of humanization of anti-lysozyme antibody, HyHEL-10.

Authors:  Takeshi Nakanishi; Kouhei Tsumoto; Akiko Yokota; Hidemasa Kondo; Izumi Kumagai
Journal:  Protein Sci       Date:  2008-02       Impact factor: 6.725

2.  Probing orientation of immobilized humanized anti-lysozyme variable fragment by time-of-flight secondary-ion mass spectrometry.

Authors:  J E Baio; Fang Cheng; Daniel M Ratner; Patrick S Stayton; David G Castner
Journal:  J Biomed Mater Res A       Date:  2011-02-09       Impact factor: 4.396

3.  Combinatorial antibody libraries from survivors of the Turkish H5N1 avian influenza outbreak reveal virus neutralization strategies.

Authors:  Arun K Kashyap; John Steel; Ahmet F Oner; Michael A Dillon; Ryann E Swale; Katherine M Wall; Kimberly J Perry; Aleksandr Faynboym; Mahmut Ilhan; Michael Horowitz; Lawrence Horowitz; Peter Palese; Ramesh R Bhatt; Richard A Lerner
Journal:  Proc Natl Acad Sci U S A       Date:  2008-04-14       Impact factor: 11.205

4.  Generation of a high-fidelity antibody against nerve growth factor using library scanning mutagenesis and validation with structures of the initial and optimized Fab-antigen complexes.

Authors:  Sherry L La Porte; Charles Eigenbrot; Mark Ultsch; Wei-Hsien Ho; Davide Foletti; Alison Forgie; Kevin C Lindquist; David L Shelton; Jaume Pons
Journal:  MAbs       Date:  2014 Jul-Aug       Impact factor: 5.857

5.  Directed evolution of single-chain Fv for cytoplasmic expression using the beta-galactosidase complementation assay results in proteins highly susceptible to protease degradation and aggregation.

Authors:  Pascal Philibert; Pierre Martineau
Journal:  Microb Cell Fact       Date:  2004-12-17       Impact factor: 5.328

Review 6.  The structural basis of antibody-antigen recognition.

Authors:  Inbal Sela-Culang; Vered Kunik; Yanay Ofran
Journal:  Front Immunol       Date:  2013-10-08       Impact factor: 7.561

7.  Structural insights into humanization of anti-tissue factor antibody 10H10.

Authors:  Alexey Teplyakov; Galina Obmolova; Thomas J Malia; Gopalan Raghunathan; Christian Martinez; Johan Fransson; Wilson Edwards; Judith Connor; Matthew Husovsky; Heena Beck; Ellen Chi; Sandra Fenton; Hong Zhou; Juan Carlos Almagro; Gary L Gilliland
Journal:  MAbs       Date:  2018-01-02       Impact factor: 5.857

8.  In memoriam: Jefferson Foote.

Authors:  E Sally Ward; Peter Jones; Tim Buss; Cristina Rada; Gregory Winter; Richard Willson
Journal:  MAbs       Date:  2021 Jan-Dec       Impact factor: 5.857

9.  Mutation of Framework Residue H71 Results in Different Antibody Paratope States in Solution.

Authors:  Monica L Fernández-Quintero; Katharina B Kroell; Florian Hofer; Jakob R Riccabona; Klaus R Liedl
Journal:  Front Immunol       Date:  2021-03-02       Impact factor: 7.561

10.  Impact of antibody framework residue VH-71 on the stability of a humanised anti-MUC1 scFv and derived immunoenzyme.

Authors:  J Krauss; M A E Arndt; Z Zhu; D L Newton; B K Vu; V Choudhry; R Darbha; X Ji; N S Courtenay-Luck; M P Deonarain; J Richards; S M Rybak
Journal:  Br J Cancer       Date:  2004-05-04       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.